Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVANOS MEDICAL, INC.AVNS · Entity 28189 | Vice President - Controller | May 07, 2021 | May 07, 2021 |
| ESAB CorpESAB · Entity 3958 | Controller, PAO | March 09, 2026 | March 11, 2026 |
| Mobility Global Inc.MBGL · Entity 392 | Chief Accounting Officer | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVANOS MEDICAL, INC.
Report date May 07, 2021 · Filed May 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,261 |
Reported balance
After 2021-05-07 transaction · row 1
1 source rowRow 1 · 2021-05-07 · Tax withholding · Disposed 243 · Balance 25,261 F1: Represents shares withheld for taxes from issuance of shares resulting from the time-based restricted stock units granted on 5/7/2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld for taxes from issuance of shares resulting from the time-based restricted stock units granted on 5/7/2020.
ESAB Corp
Report date March 09, 2026 · Filed March 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 9,475 |
Ending reported balance
After 2026-03-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-09 · Exercise / conversion · Acquired 986 · Balance 9,812 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Row 2 · 2026-03-09 · Tax withholding · Disposed 337 · Balance 9,475 F2: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2026-03-08 | Direct | 0 |
Reported balance
After 2026-03-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-09 · Exercise / conversion · Disposed 986 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. F3: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on March 8, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation.
F2: Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the reporting person's tax liability based upon the vesting of restricted stock units. No shares were sold by the reporting person to satisfy this tax liability.
F3: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. All remaining restricted stock units from this award vested on March 8, 2026.
Mobility Global Inc.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,646 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 17,646 · Balance 17,646 F1: On July 1, 2026, S&P Global Inc. ("S&P Global") completed a pro-rata spinoff distribution ("Spin-Off") of all of its shares of Issuer common stock to the holders of record of S&P Global's common stock on June 15, 2026 (the "Record Date"). F2: In connection with the Spin-Off, pursuant to the terms of the Employee Matters Agreement, dated as of June 30, 2026, by and between S&P Global and the Issuer and the anti-dilution adjustment provisions under the applicable S&P Global equity incentive plans, certain restricted stock units and performance-based restricted stock units with respect to S&P Global common stock ("S&P Global RSUs" and "S&P Global PSUs", as applicable) were equitably adjusted and converted into restricted stock units with respect to Issuer common stock ("Mobility RSUs"), based on the quotient of (i) the one-day volume weighted average price ("VWAP") of S&P Global common stock on June 30, 2026 and (ii) the one-day VWAP of Issuer common stock on July 1, 2026 (such adjustment, the "Equity Award Conversion"). F3: Represents the grant of Mobility RSUs upon the conversion of S&P Global RSUs held by the Reporting Person as of immediately prior to the Spin-Off pursuant to the Equity Award Conversion. The Mobility RSUs were granted pursuant to the Issuer's 2026 Long Term Incentive Plan (the "Mobility Plan") and are generally subject to the same terms and conditions as applied to the corresponding S&P Global RSUs. The Mobility RSUs shall vest in substantially equal installments on each of May 1, 2027, May 1, 2028 and May 1, 2029, subject to the terms of the applicable S&P Global award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 1, 2026, S&P Global Inc. ("S&P Global") completed a pro-rata spinoff distribution ("Spin-Off") of all of its shares of Issuer common stock to the holders of record of S&P Global's common stock on June 15, 2026 (the "Record Date").
F2: In connection with the Spin-Off, pursuant to the terms of the Employee Matters Agreement, dated as of June 30, 2026, by and between S&P Global and the Issuer and the anti-dilution adjustment provisions under the applicable S&P Global equity incentive plans, certain restricted stock units and performance-based restricted stock units with respect to S&P Global common stock ("S&P Global RSUs" and "S&P Global PSUs", as applicable) were equitably adjusted and converted into restricted stock units with respect to Issuer common stock ("Mobility RSUs"), based on the quotient of (i) the one-day volume weighted average price ("VWAP") of S&P Global common stock on June 30, 2026 and (ii) the one-day VWAP of Issuer common stock on July 1, 2026 (such adjustment, the "Equity Award Conversion").
F3: Represents the grant of Mobility RSUs upon the conversion of S&P Global RSUs held by the Reporting Person as of immediately prior to the Spin-Off pursuant to the Equity Award Conversion. The Mobility RSUs were granted pursuant to the Issuer's 2026 Long Term Incentive Plan (the "Mobility Plan") and are generally subject to the same terms and conditions as applied to the corresponding S&P Global RSUs. The Mobility RSUs shall vest in substantially equal installments on each of May 1, 2027, May 1, 2028 and May 1, 2029, subject to the terms of the applicable S&P Global award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 25, 2022 Filed Dec 8, 2022 01:00 UTC | ESAB Corp ESAB · Entity 3958 | Exercise / conversionCommon stock, par value $.001 | 1,924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-060272 · doc4.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock of ESAB Corporation. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:50 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 3,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023788 · doc4.xml · derivative · entry 2 Negro Renato · CIK 0001624125 · Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,377 Underlying: Common stock, par value $0.001 · 3,377 shares Expires 2025-02-17 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F4 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on February 17, 2023. Read SEC document |
| April 05, 2022 Filed Apr 8, 2022 01:50 UTC | ESAB Corp ESAB · Entity 3958 | GrantRestricted Stock Units · Derivative | 5,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023788 · doc4.xml · derivative · entry 1 Negro Renato · CIK 0001624125 · Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,770 Underlying: Common stock, par value $0.001 · 5,770 shares Expires 2024-10-25 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ESAB Corporation ("ESAB") common stock. F2 · kind: In connection with the pro-rata spin-off distribution (the "Spin-Off") by Colfax Corporation ("Colfax") of the shares of ESAB, each outstanding Colfax restricted stock unit was converted into a restricted stock unit award denominated in shares of ESAB common stock pursuant to the terms of the employee matters agreement entered into between Colfax and ESAB in connection with the Spin-Off. The number of underlying shares were adjusted in a manner intended to preserve the aggregate intrinsic value of the original Colfax restricted stock unit award. F3 · derivative.exercise_date: These restricted stock units vest in three equal annual installments beginning on October 25, 2022. Read SEC document |
| May 07, 2021 Filed May 7, 2021 21:59 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 243 | $42.82 | $10,405.26 |
DisclosureSEC source: 0001606498-21-000026 · wf-form4_162042477594348.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,261 F1 · shares: Represents shares withheld for taxes from issuance of shares resulting from the time-based restricted stock units granted on 5/7/2020. Read SEC document |
| May 03, 2021 Filed May 5, 2021 12:27 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 188 | $43.22 | $8,125.36 |
DisclosureSEC source: 0001606498-21-000019 · wf-form4_162021762771667.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,504 F1 · shares: Represents shares withheld for taxes from issuance of shares resulting from the time-based restricted stock units granted on 5/3/2018. F2 · balance_after: Reflects a further deduction in the number of shares by 182 to resolve an accounting discrepancy. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 22:17 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 2,379 | $47.29 | $112,502.91 |
DisclosureSEC source: 0001606036-21-000006 · primary_doc.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,874 F1 · shares: Represents annual grant of time-vested restricted stock units awarded to Reporting Person on 3/17/2021, with a 3 year cliff vesting period. Read SEC document |
| December 07, 2020 Filed Dec 8, 2020 19:41 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 1,640 | $45.61 | $74,800.40 |
DisclosureSEC source: 0001606498-20-000064 · wf-form4_160745646279605.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,495 F1 · shares: Represents shares withheld for taxes in connection with issuance of shares from vesting of time-based restricted stock units granted on 12/6/2018. Read SEC document |
| May 07, 2020 Filed May 11, 2020 22:14 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock · Derivative | 3,819 | $30.67 Strike: $30.67 | $117,128.73 |
DisclosureSEC source: 0001606498-20-000034 · wf-form4_158923525916365.xml · derivative · entry 3 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,819 Underlying: Common Stock · 3,819 shares Expires 2030-05-07 F3 · shares: Represents stock options issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. F4 · derivative.exercise_date: The award will vest 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 07, 2020 Filed May 11, 2020 22:14 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 2,445 | $30.67 | $74,988.15 |
DisclosureSEC source: 0001606498-20-000034 · wf-form4_158923525916365.xml · nonDerivative · entry 2 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,135 F2 · shares: Represents grant of time-vested restricted stock units awarded to Reporting Person on 5/7/2020,vesting one-third each year over a 3 year period. Read SEC document |
| May 07, 2020 Filed May 11, 2020 22:14 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 3,668 | $30.67 | $112,497.56 |
DisclosureSEC source: 0001606498-20-000034 · wf-form4_158923525916365.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,690 F1 · shares: Represents grant of time-vested restricted stock units awarded to Reporting Person on 5/7/2020, with a 3 year cliff vesting period. Read SEC document |
| May 04, 2020 Filed May 6, 2020 16:11 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 302 | $31.07 | $9,383.14 |
DisclosureSEC source: 0001606498-20-000028 · wf-form4_158878147151154.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,022 F1 · shares: Represents shares withheld for taxes from issuance of shares resulting from the time-based restricted stock units granted on 5/3/2017. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 12:17 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 599 | $42.13 | $25,235.87 |
DisclosureSEC source: 0001606498-19-000055 · wf-form4_156146501134026.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,324 F1 · shares: Represents shares withheld for taxes from vesting of time-based restricted stock units granted on 12/21/2017. Read SEC document |
| May 20, 2019 Filed May 22, 2019 10:09 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 2,940 | $42.52 | $125,008.80 |
DisclosureSEC source: 0001606498-19-000047 · wf-form4_155851975567656.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,923 F1 · shares: Represents time-vested restricted stock units issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. The award will vest on May 20, 2022, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 08, 2019 Filed May 10, 2019 13:51 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantEmployee Stock Options (right to buy) · Derivative | 2,694 | $43.59 Strike: $43.59 | $117,431.46 |
DisclosureSEC source: 0001606498-19-000040 · wf-form4_155749628439264.xml · derivative · entry 2 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,694 Underlying: Common Stock · 2,694 shares Expires 2029-05-08 F2 · shares: Represents stock options issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. F3 · derivative.exercise_date: The award will vest 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 08, 2019 Filed May 10, 2019 13:51 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 717 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-19-000040 · wf-form4_155749628439264.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,983 F1 · shares: Represents time-vested restricted stock units issued pursuant to the Avanos Medical, Inc. Equity Participation Plan. The award has a 3 year cliff vesting period, and will vest on 5/8/2022, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 05, 2019 Filed May 7, 2019 21:34 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 363 | $45.81 | $16,629.03 |
DisclosureSEC source: 0001606498-19-000035 · wf-form4_155726486753696.xml · nonDerivative · entry 3 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,266 F3 · shares: Represents shares withheld for taxes from the issuance of shares resulting form the time-based restricted stock units granted on 5/5/16. Read SEC document |
| May 05, 2019 Filed May 7, 2019 21:34 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | Tax withholdingCommon Stock | 492 | $45.81 | $22,538.52 |
DisclosureSEC source: 0001606498-19-000035 · wf-form4_155726486753696.xml · nonDerivative · entry 2 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,629 F2 · shares: Represents shares withheld for taxes from the issuance of shares resulting form the performance-based restricted stock units granted on 5/5/16. Read SEC document |
| May 05, 2019 Filed May 7, 2019 21:34 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 1,669 | $45.81 | $76,456.89 |
DisclosureSEC source: 0001606498-19-000035 · wf-form4_155726486753696.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,121 F1 · shares: Represents performance-based restricted stock units acquired from a grant on 5/5/16. Read SEC document |
| December 06, 2018 Filed Dec 7, 2018 18:50 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | GrantCommon Stock | 5,447 | $45.90 | $250,017.30 |
DisclosureSEC source: 0001606498-18-000078 · wf-form4_154420861866786.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,452 F1 · shares: Represents time-restricted share units granted to the reporting person pursuant to Avanos Medical, Inc's Equity Participation Plan, which share units are scheduled to vest on 12/6/2020 Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 18:26 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | OtherEmployee Stock Options (right to buy) · Derivative | 3,345 | $69.00 Strike: $45.53 | $230,805.00 |
DisclosureSEC source: 0001606498-18-000070 · wf-form4_153504874608853.xml · derivative · entry 4 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,583 Underlying: Common Stock · 3,345 shares Expires 2025-05-05 Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 18:26 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | OtherEmployee Stock Options (right to buy) · Derivative | 2,944 | $69.00 Strike: $45.53 | $203,136.00 |
DisclosureSEC source: 0001606498-18-000070 · wf-form4_153504874608853.xml · derivative · entry 3 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,944 shares Expires 2025-05-05 Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 18:26 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | OtherEmployee Stock Options (right to buy) · Derivative | 3,207 | $69.00 Strike: $45.53 | $221,283.00 |
DisclosureSEC source: 0001606498-18-000070 · wf-form4_153504874608853.xml · derivative · entry 2 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,207 shares Expires 2025-05-05 Read SEC document |
| August 21, 2018 Filed Aug 23, 2018 18:26 UTC | AVANOS MEDICAL, INC. AVNS · Entity 28189 | OtherEmployee Stock Options (right to buy) · Derivative | 2,504 | $69.03 Strike: $45.53 | $172,851.12 |
DisclosureSEC source: 0001606498-18-000070 · wf-form4_153504874608853.xml · derivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,504 shares Expires 2025-05-05 Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:27 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 2,374 | $0.00 Strike: $52.10 | $0.00 |
DisclosureSEC source: 0001606498-18-000046 · wf-form4_152546565249736.xml · derivative · entry 2 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,374 Underlying: Common Stock · 2,374 shares Expires 2028-05-03 F2 · derivative.exercise_date: The awards vest 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 03, 2018 Filed May 4, 2018 20:27 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 624 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-18-000046 · wf-form4_152546565249736.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,005 F1 · shares: Represents time-vested restricted stock units issued pursuant to the Halyard Health, Inc. Amended and Restated Equity Participation Plan. Read SEC document |
| December 21, 2017 Filed Jan 2, 2018 18:45 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 1,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-18-000003 · wf-form4_151491868768386.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,381 F1 · shares: Represents time-vested restricted share units, issued pursuant to the Halyard Health, Inc. Amended and Restated Equity Participation Plan, that are scheduled to vest on June 21, 2019. Read SEC document |
| May 03, 2017 Filed May 16, 2017 17:50 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantEmployee Stock Option (right to buy) · Derivative | 3,507 | $0.00 Strike: $36.74 | $0.00 |
DisclosureSEC source: 0001606498-17-000036 · wf-form4_149495699992578.xml · derivative · entry 2 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,507 Underlying: Common Stock · 3,507 shares Expires 2027-05-03 F2 · derivative.exercise_date: The awards vest 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020, subject to earlier vesting in the event of death, disability or certain other events. Read SEC document |
| May 03, 2017 Filed May 16, 2017 17:50 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | GrantCommon Stock | 851 | $0.00 | $0.00 |
DisclosureSEC source: 0001606498-17-000036 · wf-form4_149495699992578.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,410 F1 · shares: Represents time-vested restricted stock units issued pursuant to the Halyard Health, Inc. Amended and Restated Equity Participation Plan. Read SEC document |
| May 01, 2017 Filed May 3, 2017 22:59 UTC | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 779 | $39.52 | $30,786.08 |
DisclosureSEC source: 0001606498-17-000028 · wf-form4_149385235956224.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,559 F1 · balance_after: Total based on corrections made in Form 4/A filed January 19, 2017. Read SEC document |
| May 01, 2016 Filed Jan 19, 2017 20:43 UTC Amendment | AVANOS MEDICAL, INC. HYH · Entity 28189 | Tax withholdingCommon Stock | 637 | $28.16 | $17,937.92 |
DisclosureSEC source: 0001606036-17-000013 · primary_doc.xml · nonDerivative · entry 1 Negro Renato · CIK 0001624125 · Vice President - Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,320 F1 · shares: Due to a calculation error, the original Form 4 filed on May 3, 2016 incorrectly reported the number of securities withheld. The value reflects the actual amount of securities withheld in the transaction. F2 · balance_after: The original Form 4 filed on May 3, 2016 is amended by this Form 4 amendment to reflect the correct number of shares beneficially owned by the Reporting Person after the transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.